A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: wheel (22), pedals (5)

Breast lipomodelling - patient information

Description
This factsheet explains what breast lipomodelling is, what the procedure involves and what the potential risks are.
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Breast-lipomodelling-patient-information.pdf

Charging overseas visitors

Description
The NHS is a free healthcare system. Whether or not a person is eligible to benefit from this is based upon
Url
/HealthProfessionals/Clinical-law-updates/Charging-overseas-visitors.aspx

Ibrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Ibrutinib • CLL – Ibrutinib Indication • NICE TA 429 recommends ibrutinib alone within its marketing authorisation as
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib.pdf

Chlorambucil_7day

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (7 day) There are several versions of this protocol each using a different dose or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7day.pdf

Chlorambucil_14day

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (14 day) There are several versions of this protocol each using a different dose or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14day.pdf

CytarabineSC

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE SC Regimen • Acute Myeloid Leukaemia – Cytarabine SC Indication • Acute myeloid leukaemia in those 60 years
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC.pdf

Cytarabine3000

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (3000mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (3000mg/m2) Indication • Consolidation
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine3000.pdf

AmsacrineCytarabineEtoposide_MACE

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Etoposide (MACE) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

Topotecan (1,8,15)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indication Second-line or subsequent treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf

Topotecan (1,8)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Second-line or subsequent treatment of platinum
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf
551 to 560 of 1000
Previous … 54 55 56 57 58 … Next